Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NEK3

RBC: NEK3 · Substrate: MBP ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Neratinib46.30.60
Pacritinib43.00.45
Defactinib36.00.45
Crizotinib24.80.58
Gilteritinib23.00.51
Fostamatinib19.60.61
Capivasertib17.90.64
Dabrafenib16.30.63
Selpercatinib15.60.64
Tivozanib15.50.67
Abemaciclib14.50.56
Canertinib14.40.67
Imatinib13.50.72
Deucravacitinib13.20.72
Remibrutinib12.30.72

Known variants

No variants catalogued.
Open in new tab